Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

In response: Considerations regarding compounding pharmacies and GLP-1 agonists. | Pepdox

Home
Search
PMID 38600000

In response: Considerations regarding compounding pharmacies and GLP-1 agonists.

The American journal of emergency medicine2024PMID: 38600000

View on PubMed DOI: 10.1016/j.ajem.2024.03.037

Authors

Long, Brit; Pelletier, Jessica; Koyfman, Alex; Bridwell, Rachel E

Keywords

Adverse eventComplicationCompoundingDiabetesEndocrineGLP-1 agonistLiraglutideSemaglutideSide effectWeight loss